Bromhexin, tablets 8 mg 28 pcs

Mucolytic (secretolytic) agent, has expectorant and weak anti-cough effect. Reduces sputum viscosity (depolymerizes mucoprotein and mucopolysaccharide fibers, increases serous component of bronchial secretion); activates atrial fibrillation epithelium, increases volume and improves sputum discharge. Stimulates production of endogenous surfactant providing stability of alveolar cells during breathing.

Indications

Diseases of the respiratory tract accompanied by difficulty in the discharge of viscous sputum: tracheobronchitis, bronchitis of various etiologies (including complicated by bronchiectasis), bronchial asthma, pulmonary tuberculosis, pneumonia (acute and chronic), cystic fibrosis.
Sanitation of the bronchial tree in the preoperative period and during therapeutic and diagnostic intrabronchial manipulations, prevention of accumulation of thick viscous sputum in the bronchi after surgery.

Pharmacological effect

Mucolytic (secretolytic) agent, has an expectorant and weak antitussive effect. Reduces the viscosity of sputum (depolymerizes mucoprotein and mucopolysaccharide fibers, increases the serous component of bronchial secretions); activates the ciliated epithelium, increases volume and improves sputum discharge. Stimulates the production of endogenous surfactant, which ensures the stability of alveolar cells during respiration.

Special instructions

During treatment, it is necessary to take a sufficient amount of fluid, which increases the expectorant effect of bromhexine.

In children, treatment should be combined with postural drainage or vibration massage of the chest, which facilitates the removal of secretions from the bronchi

Active ingredient

Bromhexine

Composition

1 tablet contains:
active substance:
Bromhexine hydrochloride – 0.008 g
excipients:
sucrose (sugar) – 0.081 g
potato starch – 0.010 g
calcium stearate – 0.001 g

Contraindications

Hypersensitivity, peptic ulcer, pregnancy (first trimester); lactation period; children’s age (up to 6 years).

With caution:

Renal and/or liver failure; diseases of the bronchi, accompanied by excessive accumulation of secretions, a history of gastric bleeding.

Side Effects

Allergic reactions, nausea, vomiting, dyspepsia, exacerbation of gastric and duodenal ulcers, dizziness, headache, increased activity of liver transaminases (extremely rare).

Interaction

Do not prescribe simultaneously with drugs that suppress the cough center (including codeine), since this complicates the discharge of liquefied sputum (accumulation of bronchial secretions in the respiratory tract).

Manufacturer

Update of PFC JSC, Russia